Sunday, 20 September 2026European Markets

ALUMEXX N.V. Stock Bullish Momentum With A 21.9% Jump Today

Loading stream...

(VIANEWS) - The Market ended the session with ALUMEXX N.V. (ALX.AS) jumping 21.9% to €0.84 on Thursday, after three successive sessions in a row of losses. AEX-Index fell 0.48% to €789.88, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

ALUMEXX N.V.'s last close was €0.69, 12.74% under its 52-week high of €0.79.

About ALUMEXX N.V.

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.12.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 6.96. Meaning, the purchaser of the share is investing €6.96 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.26%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 303.1%, now sitting on 19.57M for the twelve trailing months.

Yearly Top and Bottom Value

ALUMEXX N.V.'s stock is valued at €0.84 at 21:31 EST, higher than its 52-week high of €0.79.

Moving Average

ALUMEXX N.V.'s worth is way above its 50-day moving average of €0.69 and way above its 200-day moving average of €0.67.

More news about ALUMEXX N.V. (ALX.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com
ALUMEXX N.V. Stock Bullish Momentum With A 21.9% Jump Today | ViaNews EU